Transmission of Drug‐Resistant Tuberculosis among Treated Patients in Shanghai, China
Author(s) -
Xia Li,
Ying Zhang,
Xin Shen,
Guomiao Shen,
Xiaohong Gui,
Bin Sun,
Jian Mei,
Kathryn DeRiemer,
Peter M. Small,
Qian Gao
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/511985
Subject(s) - tuberculosis , drug resistance , medicine , mycobacterium tuberculosis , regimen , transmission (telecommunications) , drug , drug resistant tuberculosis , extensively drug resistant tuberculosis , disease , multi drug resistant tuberculosis , pharmacotherapy , intensive care medicine , pharmacology , microbiology and biotechnology , biology , pathology , electrical engineering , engineering
We sought to determine whether patients who had therapy failure with increasingly drug-resistant strains of tuberculosis had primary or acquired drug resistance, by genotyping the initial and subsequent drug-resistant clinical isolates of Mycobacterium tuberculosis collected from patients by the Shanghai Centers for Disease Control and Prevention over the course of a 5-year period. The vast majority of patients (27/32) had primary drug resistance, indicating transmission of a drug-resistant strain of M. tuberculosis. Only 16% (5/32) had acquired drug resistance because of a poor treatment regimen or nonadherence to an adequate regimen. Our findings highlight the urgency of increasing efforts to interrupt the transmission of drug-resistant tuberculosis in communities and facilities in Shanghai, China.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom